AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
Medical Device Network on MSN

AliveCor secures FDA approval for next-generation Kardia 12L ECG system

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
MassDevice

AliveCor earns another FDA nod for AI-powered 12-lead ECG tech

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
Medical Device and Diagnostic Industry (MD+DI)

AliveCor’s Tumultuous Week

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
Healio

Chamber Enlargements and Axis ECG 5

Hypertrophic obstructive cardiomyopathy (HOCM) is a pathologic cardiac condition in which the interventricular septum is abnormally thickened. The classic finding in HOCM is large dagger-like “septal ...
Healio

Chamber Enlargements and Axis ECG 13

This patient had severe mitral stenosis from rheumatic mitral valve disease causing massive left atrial enlargement. Note the morphology of the PVC in lead V1. The R is greater than the R' in a right ...